Taken together, these results indicated that HDAC7 as a potential prognostic marker for liver cancer, and LukS-PV can downregulate the high expression of HDAC7 by targeting C5aR1 in HCC cells. The gene discussed is HDAC7; the disease is hepatocellular carcinoma.